mamacrowd-logo
InvestRaiseFund&CrowdGuideNews
LoginSign up
Geldis
GELDIS | Mamacrowd

Geldis

Healthcare

The Italian oral care brand that combines technologically advanced formulas with innovative flavors to make the end-consumer experience unique.

  • Revenues tripled in the last two years with over €1mln in 2022 and positive EBITDA of 23.7%

  • Active community of +16,000 Dentists and Dental Hygienists participating in product development

  • 1 industrial patent and 2 international trademarks

  • Oral care market: M&A in turmoil (Marvis, Captain's Pasta)

TAX Bonus

Innov SME

SIM

LP

    Project
    Team and Shareholders
    Market and Target
    Business Model
    Financial projections
    Use of funds
    Rewards for Investors
immagine copertina
The content of this page has been translated automatically

Project

What is missing from the oral hygiene market?

A brand that listens to consumers, speaks directly to professionals, and creates products other than those that make brushing teeth a boring habit. A brand that makes oral hygiene a pleasure: Geldis!

Geldis' mission is to empower people to choose from a range of toothpastes, mouthwashes, toothbrushes, and more, opting for flavors and combinations they love.

Brushing your teeth every day is a necessary habit for the health of your mouth. Why not make this repetitive act beautiful, engaging and enjoyable?

No more seen-and-seen flavors, packaging and colors! Geldis combines technologically advanced formulas with unique aesthetics to meet the needs of a diverse target group of people who are not satisfied with what the market offers.

The company was founded in 2016 by patenting Geldis Daily Cleanser, an antibacterial gel for the hygiene of mobile braces, clear templates, and splints.

In a short time, the gel became a must-have for patients and professionals tired of seeing yellowed and ruined braces.

From there, a solid community of professionals was created who embraced the Geldis communication style with enthusiasm, as they were used to always interfacing only with intermediaries and not directly with the founders of a company that listened carefully to their suggestions.

From this continuous and direct exchange, Doctor Floss was born.

Floss with the technological and compositional features required, but with a Geldis touch: flavors!

Geldis goes beyond market standards, giving even the Dentist and Dental Hygienist the opportunity to recommend products that allow their patients to express themselves by choosing from Chocolate, Mint, through Lime and Bergamot floss.

Geldis chooses the best ingredients, focusing on vegan and cruelty free formulas, and respecting the indications of Professionals and Ministerial Guidelines, to guarantee the best in terms of health and prevention.

For the past 5 years, some of the values that have distinguished the company are listening and direct communication, without frills.

Social is not just a showcase, but a very powerful tool that allows the brand to ask questions, question, understand and evolve. Geldis has tripled revenues in the last two years and closed 2022 with a turnover of over € 1 mln and positive EBITDA (+23.7%) selling only on the Italian market.

The sales strategy is transversal and uses different channels: pharmaceutical distributors, Pharmacies, Dental Practices, e-commerce and Amazon. Production is outsourced: this allows maximum flexibility with a view to growth and to select excellent subcontractors depending on the product to be made.

Geldis' business model is scalable, and the company has structured itself to support the intense and consistent growth that awaits it, including abroad.

 

Tax benefits of 30 percent apply on Geldis.

 

Geldis reserves the right of "liquidation preference" for all investors who join the campaign, who will therefore be reimbursed first in the event of an exit than the company's other shareholders (according to the order of preference stated in the bylaws). All conditions are published in the bylaws found in the Documents section.

 

Optional Rubrication service is available on the Geldis campaign for a fee.

 
 
20230315110336_85f5e358_Slide%202

Want to find out more about this project?

Register or log in, if you already have an account, to view all information in detail

Sign up
Login

Geldis

Healthcare

Closed 29/05/2023
funded

Total funding

610.080 €

Goal min 300k €

Goal max 1.000k €

Professional Investor

Professional Inv.


135 investors

209% Goal min


Min order

249,75 €


Pre-Money

5Mln €

The information on the offer is not subject to approval by Consob. The Offering company is solely responsible for the completeness and truthfulness of the data and information provided by the latter. The investor's attention is also drawn to the fact that the investment, even indirect, through OICR or companies that invest mainly in financial instruments issued by innovative startups and SMEs is illiquid and characterised by a very high risk.
mamacrowd-logo

About us

Who we are

Press

Power User program

News

Carrers

Company informations

Real Estate Statistics

Crowdfunding services

Guide for the investor

Crowdfunding services

Investment costs

Risk warning

Alternative allowance regime

Tax benefits

Arbitrator for financial disputes

Dematerialized system

Trust company header service

Support

How to start

FAQ

Contacts

Terms & Conditions

Power User Terms & Conditions

Privacy Policy

Cookies Policy

Recovery Policy

Conflicts of Interest Policy

Handle Cookies

Warnings pursuant to art. 19 para. 2
the crowdfunding services provided by Mamacrowd do not fall under the deposit guarantee scheme established in accordance with Directive 2014/49/EU; the securities and instruments eligible for crowdfunding that can be acquired through this crowdfunding platform do not fall under the investor compensation scheme established in accordance with Directive 97/9/EC.

 

© 2025 Mamacrowd Srl a company of Azimut Group - VAT number IT07464370969 - Via Timavo 34, 20124 MI - SC € 95.417,54 fully paid up - Crowdfunding service provider authorised by resolution No. 22876 of 08/11/2023

  • Italiano

  • English

    Invest
      Invest in Startup/PMI and real estate projects
      Investor guide

    Raise
      Candidate a project

  • Sign Up
    Login
  • Italiano

  • English

Let us get to know you better

Mamacrowd and partners operate globally and can, upon acquiring your consent through the "Accept all", "Accept only necessary" or "Set preferences" commands, use cookies for statistical, advertising and also profiling purposes, own or third-party, to modulate the provision of the service in a personalized way and in line with your preferences.
In case of refusal we will only use the necessary cookies. For more information, read our Cookies Policy

Set preferences
Accept only necessary